E.K. Silverman

571 total citations
21 papers, 411 citations indexed

About

E.K. Silverman is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cancer Research. According to data from OpenAlex, E.K. Silverman has authored 21 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 3 papers in Physiology and 3 papers in Cancer Research. Recurrent topics in E.K. Silverman's work include Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers), Pulmonary Hypertension Research and Treatments (4 papers) and Respiratory Support and Mechanisms (4 papers). E.K. Silverman is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers), Pulmonary Hypertension Research and Treatments (4 papers) and Respiratory Support and Mechanisms (4 papers). E.K. Silverman collaborates with scholars based in United States, United Kingdom and Denmark. E.K. Silverman's co-authors include Ruth Tal‐Singer, Bruce E. Miller, Lisa Edwards, David A. Lomas, Harvey O. Coxson, Craig P. Hersh, Morten Dahl, Joseph Loscalzo, Ngoc P. Ly and Catherine S. Berkey and has published in prestigious journals such as American Journal of Epidemiology, European Respiratory Journal and Thorax.

In The Last Decade

E.K. Silverman

18 papers receiving 397 citations

Peers

E.K. Silverman
Weining Xiong China
Masaru Nishitsuji Japan
Roy R. Woldhuis Netherlands
Yasuko Aida Japan
Gry Haaland Norway
Ethel B. Tolker United States
Marianne Kaschak United States
Mary Ann Babyak United States
Sahar Hamadi United States
Keiko Nunomiya Japan
Weining Xiong China
E.K. Silverman
Citations per year, relative to E.K. Silverman E.K. Silverman (= 1×) peers Weining Xiong

Countries citing papers authored by E.K. Silverman

Since Specialization
Citations

This map shows the geographic impact of E.K. Silverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.K. Silverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.K. Silverman more than expected).

Fields of papers citing papers by E.K. Silverman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.K. Silverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.K. Silverman. The network helps show where E.K. Silverman may publish in the future.

Co-authorship network of co-authors of E.K. Silverman

This figure shows the co-authorship network connecting the top 25 collaborators of E.K. Silverman. A scholar is included among the top collaborators of E.K. Silverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.K. Silverman. E.K. Silverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hunninghake, Gary M., et al.. (2023). Interstitial Lung Abnormalities Are Associated With Increased Mortality in PRISm. A5936–A5936. 1 indexed citations
2.
Rose, J.A., Takuya Hino, Akinori Hata, et al.. (2022). Prevalence and Outcomes of Subclinical Interstitial Lung Disease in COPDGene. A5268–A5268.
3.
Moll, Matthew, Adel R. Boueiz, Abhisek Ghosh, et al.. (2021). Development of a Blood-Based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease. A1153–A1153. 1 indexed citations
4.
Morrow, Jarrett D., Iván O. Rosas, Imre Noth, et al.. (2020). Smoking Related Co-Methylation Networks Reveal Checkpoint-Related Signatures of IPF and COPD in Leukocytes and Lung Tissue. A7831–A7831. 1 indexed citations
5.
Kinney, Gregory L., Jennifer L. Black‐Shinn, Francine L. Jacobson, et al.. (2014). Arthritis and back pain impact respiratory-specific quality of life measures in smokers with and without COPD. Osteoarthritis and Cartilage. 22. S223–S224. 1 indexed citations
6.
Silverman, E.K. & Joseph Loscalzo. (2012). Developing New Drug Treatments in the Era of Network Medicine. Clinical Pharmacology & Therapeutics. 93(1). 26–28. 30 indexed citations
7.
Castaldi, Peter J., David M. Kent, Edward J. Campbell, et al.. (2009). Development of Predictive Models for Airflow Obstruction in Alpha-1-Antitrypsin Deficiency. American Journal of Epidemiology. 170(8). 1005–1013. 17 indexed citations
8.
Johannessen, Ane, et al.. (2009). Gender Differences in COPD – Are Women More Susceptible to Smoking Effects?.. A3750–A3750. 2 indexed citations
9.
Lomas, DA, et al.. (2009). Serum Surfactant Protein D Is Associated with Exacerbations of COPD.. A5352–A5352. 3 indexed citations
10.
11.
Yamashiro, Tsuneo, Shin Matsuoka, Raúl San Jośe Estépar, et al.. (2009). Quantitative Airway Assessment on Computed Tomography in Patients with Alpha-1 Antitrypsin Deficiency.. A5592–A5592. 6 indexed citations
12.
Ej, Campbell, et al.. (2009). Development of Predictive Models for Airflow Obstruction in Alpha-1 Antitrypsin Deficiency.. A3499–A3499. 2 indexed citations
13.
14.
Silverman, E.K., et al.. (2009). Computed Tomographic Metrics of Airway Disease and Emphysema in Severe COPD.. A6201–A6201. 1 indexed citations
15.
Foreman, Marilyn G., Dawn L. DeMeo, Craig P. Hersh, et al.. (2008). Polymorphic variation in surfactant protein B is associated with COPD exacerbations. European Respiratory Journal. 32(4). 938–944. 49 indexed citations
16.
Lomas, David A., E.K. Silverman, Lisa Edwards, et al.. (2008). Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax. 63(12). 1058–1063. 157 indexed citations
17.
Loo, Wei Jing, et al.. (2006). Smoking related COPD and facial wrinkling: Is there a common susceptibility?. 2(3). 106–106. 15 indexed citations
18.
DeMeo, Dawn L., Sorachai Srisuma, Augusto A. Litonjua, et al.. (2006). The SERPINE2 gene is associated with chronic obstructive pulmonary disease. 1(4). 143–143. 12 indexed citations
19.
Dahl, Morten, Craig P. Hersh, Ngoc P. Ly, et al.. (2005). The protease inhibitor PI*S allele and COPD: a meta-analysis. European Respiratory Journal. 26(1). 67–76. 90 indexed citations
20.
Fe, Speizer, Drazen Jm, ST Weiss, et al.. (1999). Bronchodilator responsiveness and serum total IgE levels in families of probands with severe early-onset COPD. European Respiratory Journal. 14(5). 1009–1014. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weining Xiong Breakdown of academic impact, for papers by Masaru Nishitsuji Breakdown of academic impact, for papers by Roy R. Woldhuis Breakdown of academic impact, for papers by Yasuko Aida Breakdown of academic impact, for papers by Gry Haaland Breakdown of academic impact, for papers by Ethel B. Tolker Breakdown of academic impact, for papers by Marianne Kaschak Breakdown of academic impact, for papers by Mary Ann Babyak Breakdown of academic impact, for papers by Sahar Hamadi Breakdown of academic impact, for papers by Keiko Nunomiya
Rankless by CCL
2026